Fortress Biotech Inc
NASDAQ:FBIO 4:00:00 PM EDT
| Market Cap (Intraday) | 48.38M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.87 |
| 50-Day MA | $1.98 |
| 200-Day MA | $2.02 |
Fortress Biotech Inc Stock, NASDAQ:FBIO
1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida 33154
United States of America
Phone: +1.781.652.4500
Number of Employees: 186
Description
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.